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Introduction
Caloric restriction (CR), also known as dietary restriction, is a well-known dietary intervention that suppresses age-related pathophysiology and extends lifespan in a number of animal models (Chung et al., 2013) . However, the precise underlying mechanisms of the effects of CR remain to be established (Chung et al., 2013; Guarente, 2013) . CR induces metabolic remodeling in several organs and tissues, including white adipose tissue (WAT). We have reported previously that CR promotes de novo fatty acid biosynthesis, activates mitochondrial biogenesis, suppresses oxidative stress, and modulates the adipokine expression profile in rodent WAT (Chujo et al., 2013; Fujii et al., 2017; Okita et al., 2012 Okita et al., , 2015 .
WAT plays a central role in the regulation of both energy storage and expenditure and is also directly involved in the regulation of lifespan. CCAAT/enhancer-binding protein (C/EBP), C/EBP and peroxisome proliferator-activated receptor  (PPAR) are master transcriptional regulators of adipocyte differentiation (Farmer, 2006) . Mice in which C/EBP is replaced with C/EBP (/ mice) live longer than their wild-type counterparts (Chiu et al., 2004) , whereas hetero-deficient PPAR knockout (KO) mice exhibit shortened lifespan ACCEPTED MANUSCRIPT Argmann et al., 2009) . Hence, the characteristics of WAT seem to influence the age-associated pathophysiology and lifespan of rodents.
A C C E P T E D M A N U S C R I P T
Fibroblast growth factor 21 (FGF21), a member of the endocrine FGF superfamily, was initially identified as a hepatokine that regulates lipid and glucose metabolism (Kharitonenkov et al., 2005; Nishimura et al., 2000) . In the liver, Fgf21 expression is positively regulated by several transcription factors, including PPARα (Dutchak et al., 2012) , carbohydrate responsive element-binding protein (ChREBP) (Zhang et al., 2011) , and activating transcription factor 4 (ATF4) (Schaap et al., 2013) , and is negatively regulated by sterol regulatory element binding protein 1c (SREBP-1c) (Zhang et al., 2011) . FGF21, which is mostly secreted from the liver into the bloodstream, can bind to the FGF receptor (FGFR) and beta-klotho (KLB) receptor complex in target tissues, such as WAT and muscle, which activates local downstream signaling (Ding et al., 2012; Kurosu et al., 2007; Ogawa et al., 2007) . FGF21-FGFR1/KLB signaling upregulates the expression of genes involved in glucose uptake, lipogenesis, and lipolysis (Kharitonenkov et al., 2005; Kurosu et al., 2007) . However, recently, Fgf21 has been shown to be expressed not only in liver, but also in other tissues, including WAT, brown adipose tissue, muscle, and pancreas (Fon Tacer et al., 2010) . In WAT and 3T3-L1 adipocytes, Fgf21 expression is upregulated by multiple transcription factors,
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including PPARγ (Dutchak et al., 2012; Muise et al., 2008) , ChREBP (Oishi et al., 2011; Sánchez et al., 2009) , and ATF4 (Wan et al., 2014) . Interestingly, SREBP-1c, which is a negative regulator of FGF21 in the liver, increases Fgf21 transcription in WAT (Véniant et al., 2012) . Moreover, Fgf21 expression is upregulated by PPARγ and PPARγ coactivator-1α
(PGC-1α) via feed-forward autocrine/paracrine loops (Dutchak et al., 2012; Fisher et al., 2012) in WAT.
FGF21 transgenic (Tg) mice live longer than their wild-type counterparts (Zhang et al., 2012) ; they also exhibit enhancement of FA oxidation and ketogenesis, greater insulin sensitivity, and suppression of the growth hormone/insulin-like growth factor-1 signaling pathway (Potthoff et al., 2009; Zhang et al., 2012 ). This phenotype is somewhat similar to that of rodents subjected to CR. Moreover, mRNA expression of Fgf21 is upregulated in the WAT of adipose tissue-specific nuclear form of SREBP-1c (nSREBP-1c) Tg mice (Véniant et al., 2012) . In addition, we have shown that CR-induced WAT remodeling is regulated by SREBP-1c, a master regulator of fatty acid biosynthesis (Fujii et al., 2017) . However, adipose tissue-specific nSREBP-1c Tg mice show features of congenital generalized lipodystrophy and short lifespan (Shimomura et al., 1998; Véniant et al., 2012) . Therefore, factors other than SREBP-1c might also contribute to the beneficial effects of CR. Furthermore, there have been
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A C C E P T E D M A N U S C R I P T 8 few reports concerning the importance of the FGF21 axis in the beneficial effects of CR, particularly in WAT. Therefore, in the present study, we aimed to determine the effects of aging superimposed upon CR on the expression of FGF21 and its upstream regulators, receptor complex, and downstream mediators. To do this, we evaluated the time course of the CR-induced effects, focusing on WAT.
Material and Methods

Animals and diet
The present study was approved by the Ethics Review Committee for Animal
Experimentation at Tokyo University of Science (Approval No. Y18060). Male 5-7-week-old
Wistar rats (Clea, Tokyo, Japan) were maintained under specific pathogen-free, temperature (23ºC) and light-controlled (lights on 08:00-20:00) conditions in the Laboratory Animal
Center of the Faculty of Pharmaceutical Sciences, Tokyo University of Science. All rats were provided with water and fed ad libitum with a Charles River Formula-1 diet (Oriental Yeast,
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A C C E P T E D M A N U S C R I P T 9 Tokyo, Japan). At 12 weeks of age, the rats were divided into two groups, one of which was fed ad libitum (AL group) and the other was calorie-restricted (CR group; 70% of AL energy intake). At 3.5, 9, or 24 months of age, rats were euthanized under isoflurane anesthesia (Mylan, Canonsburg, PA, USA). The feeding and euthanasia schedule are shown in Fig. S1 .
Prior to euthanasia, the AL and CR groups were further divided into fed and fasted subgroups. Half of the CR rats were provided with food 30 min prior to the start of the dark phase and then euthanized the following morning, when most of them had finished eating (CR-fed), while the other half were not provided with food overnight and were euthanized the following morning (CR-fasted). Therefore, the CR-fasted rats had been fasted for 20-24 h before euthanasia. In addition, half of the AL rats were euthanized at the same time as the CR-fed group, without having had their food removed the previous evening (AL-fed), while the other half were euthanized 20-24 h after their food was removed at the start of the preceding light phase (AL-fasted). Therefore, there was a total of 12 groups (3.5, 9, or 24 months; AL or CR; and fed or fasted), each of which consisted of five or six rats.
After the animals were euthanized, their total body masses were measured. Liver, epididymal white adipose tissue (eWAT), and soleus muscle (SOL) were collected and washed using phosphate-buffered saline, and their masses were also measured. Body mass,
A C C E P T E D M A N U S C R I P T 10 liver mass, and eWAT mass are shown in Fig. S2 . Thereafter, the tissues were immediately diced, frozen in liquid nitrogen, and stored at −80°C until analysis. Blood samples were collected in 1.5 mL microtubes containing ethylenediaminetetraacetic acid. After centrifugation (2,500 × g, 10 min, 4ºC), the resultant supernatants were collected as plasma samples and stored at −80°C until analysis.
Plasma biochemical analysis
Plasma FGF21 concentration was measured using a Mouse/Rat FGF-21 Quantikine ELISA kit (R&D Systems, Minneapolis, MN, USA), according to the manufacturer's protocol.
Cell culture and differentiation into adipocytes
For the following methods, chemicals were purchased from Fujifilm Wako Pure Chemical (Osaka, Japan), except where stated. Mouse 3T3-L1 pre-adipocytes (Riken BioResource Research Center, Tsukuba, Japan) were maintained in Dulbecco's modified Eagle's medium (D-MEM) (low glucose) containing 10% fetal bovine serum (Thermo Fisher
Scientific, Waltham, MA, USA) and 1% penicillin/streptomycin (Sigma-Aldrich, St. Louis, MO, USA). Differentiation of 3T3-L1 pre-adipocytes into adipocytes was performed as reported previously . Day 12 3T3-L1 adipocytes, which were fully differentiated and had accumulated significant triglyceride, were used in this study.
Vector constructs
Fgf21 cDNA was amplified from mouse liver cDNA by PCR using PrimeSTAR (Toyobo, Osaka, Japan) and subcloned into BamH1-and EcoR1-digested pBluescript II SK(+). Fgf21 cDNA fragments obtained by BamH1 and EcoR1 digestion of the subcloned vector were then cloned into pMXs-AMNN-Puro vector (Fujii et al., 2017) . Oligonucleotide primers for Fgf21 were chemically synthesized by Eurofins Genomics (Tokyo, Japan) with the following sequences: 5´-TTT GGA TCC GCC ACC ATG GAA TGG ATG A -3´ (BamH1) and 5´-TTT GAA TTC TCA GGA CGC ATA GCT GG -3´ (EcoR1), containing the restriction enzyme sites indicated in italics.
FGF21 overexpression in 3T3-L1 cells
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FGF21 overexpressing (OE) 3T3-L1 cells were generated using retroviral infection, as reported previously (Fujii et al., 2017) . Briefly, the pMXs-AMNN-puro (mock) or the pMXs-AMNN-FGF21-puro (FGF21 OE) vectors were transfected into Plat-E cells (kindly provided by T. Kitamura, University of Tokyo, Japan) using FuGENE ® 6 (Promega, Madison, WI, USA), according to the manufacturer's protocol. The supernatant from each virus-containing culture was then collected 2 days later and filtered through 0.22 µm filters (Millipore, Billerica, MA, USA). To obtain stable cell lines, 3T3-L1 cells were incubated in virus-containing medium for 2 days, followed by selection with 5 µg/mL puromycin for 5 days.
Reverse transcription-quantitative real-time PCR
Total RNA extraction and reverse transcription-quantitative real-time PCR (RT-qPCR) were performed as previously described (Chujo et al., 2013) . Briefly, total RNA was extracted from tissues and cells using RNAiso PLUS (Takara Bio, Otsu, Japan) and subsequently purified with FastPure TM RNA kits (Takara Bio), according to the manufacturer's protocol.
The purified RNA was subjected to reverse transcription using PrimeScript TM Reverse
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Transcriptase (Takara Bio) and random hexamers (Takara Bio). RT-qPCR was then performed using an Applied Biosystems 7300 Real-time PCR system (Thermo Fisher Scientific) and Thunderbird SYBR qPCR Mix (Toyobo), according to the manufacturers' protocols. Primer pair sequences are listed in Table S1 .
Western blotting
Total protein extraction and western blotting were performed as reported previously Goat Anti-Rabbit IgG (H+L) (111-036-045, Jackson Immuno Research, West Grove, PA, USA) was used as the secondary antibody. The antibody-bound proteins were visualized with ImmunoStar ® LD reagent and a LAS3000 Image Analyzer (Fujifilm, Tokyo, Japan) and the data generated were analyzed using Multigauge software (Fujifilm).
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Statistical Analysis
Data are presented as mean ± standard error of the mean (SEM). Statistical significance was determined using the Mann-Whitney U, Steel, or Steel-Dwass tests. Detailed statistical information is provided in the figure legends. Statistical analyses were performed using R software (Version 3.4.1, R Core Team, 2017).
Results
Fgf21 expression and plasma FGF21 concentration
The Fgf21 gene is expressed in various tissues, but especially in eWAT, liver, and soleus muscle (SOL) (Fon Tacer et al., 2010; Kharitonenkov et al., 2005; Nishimura et al., 2000) . To compare expression in the target tissues, we first measured Fgf21 expression levels in the three tissues. The expression levels of Fgf21 mRNA and FGF21 protein were clearly higher in eWAT and liver than in SOL (Fig. 1A, B) . These findings are consistent with those obtained in previous studies conducted in mice (Keipert et al., 2014; Vandanmagsar et al., 2016) . To
further understand the effects of aging and CR on FGF21, we measured the plasma FGF21
concentrations of rats in the four experimental groups. In AL-fed rats, the plasma FGF21 concentration increased with age (Fig. 1C ), but at 9 and 24 months of age it was much lower in CR-fasted rats than in AL or CR-fed rats (Fig. 1C) .
To further explore the links between the differences in plasma FGF21 concentration and tissue expression, we subsequently measured Fgf21 mRNA and protein expression levels in both liver and eWAT. The expression of Fgf21 mRNA also increased with age in the liver of AL-fed rats ( Fig. 1D ) and FGF21 protein expression was higher at 9 months of age (Fig. 1E ).
In the liver of 9-month-old CR rats, Fgf21 mRNA expression was lower in the fasted state, and by 24 months of age, Fgf21 mRNA expression was also lower in the fed state (Fig. 1D) .
However, the CR-induced differences in FGF21 protein expression did not reach significance.
In eWAT, Fgf21 mRNA and protein expression also increased with age in AL-fed rats (Fig 1F, G) . At 9 and 24 months of age, Fgf21 mRNA expression was higher in the eWAT of CR-fed rats (Fig. 1F ) and FGF21 protein expression was slightly higher (p=0.07) in CR-fed rats at 9 months of age ( Fig 1G) . Thus, CR significantly upregulated FGF21 expression in fed rats by 9 months of age (p=0.03, Fig. S3 ).
Overall, it appears that aging significantly increases Fgf21 expression in the liver and
eWAT, resulting in higher plasma concentrations in AL rats of advancing age. In contrast, CR increases Fgf21 expression in eWAT but not in the liver in the fed state, particularly around 9 months of age.
Figure 1
A C C E P T E D M A N U S C R I P T Total RNA was extracted from eWAT, liver, and SOL of AL-fed rats at 3.5 months of age. The mRNA expression of Fgf21 was quantified using RT-qPCR (n=5-6). Tbp was used as a reference gene and to normalize the expression of the target gene (A). Total protein was extracted from eWAT, liver, and SOL of AL-fed rats at 3.5 months of age and quantified by western blotting, using anti-FGF21 and LMNB1 antibodies (B, upper panel).
LMNB1 was used as a reference protein and to normalize target protein expression. The quantitative data (n=3) are shown in B, lower panel. Plasma was collected from the four groups (AL-fed, AL-fasted, CR-fed and CR-fasted) of rats at 3.5, 9, and 24 months of age. FGF21 plasma concentration was measured by ELISA (n=5-6) (C). Total RNA was extracted from the liver and eWAT from the four groups (AL-fed, AL-fasted, CR-fed and CR-fasted) of rats at 3.5, 9, and 24 months of age. The mRNA expression of Fgf21 in the liver (D) and eWAT (F)
were quantified using RT-qPCR (n=5-6), as described above (D, F). Total protein was extracted from the liver and eWAT of the four groups (AL-fed, AL-fast, CR-fed and CR-fast) of rats at 3.5, 9, and 24 months of age.
FGF21 protein expression in the liver (E) and eWAT (G) was quantified by western blotting, as described above (E, G). The quantitative data (n=5-6) are shown in the lower panels. Values shown in all panels are means ± SEM. *P < 0.05 vs. AL, †P < 0.05 vs. fed, analyzed using the Steel-Dwass test in the same age group. §P < 0.05, § §P < 0.01 vs. 3.5 months of age, analyzed using the Steel test within the AL-fed group. N.D.: not-detected.
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Expression of FGF21-regulating factors in the liver
To elucidate the mechanisms involved in the age-and CR-induced differences in Fgf21 expression, the expression levels of several transcription factors previously reported to regulate Fgf21 expression were measured using RT-qPCR.
In the liver of AL-fed rats, the mRNA expression levels of Pparα and Chrebp varied little during the experimental period ( Fig. 2A, B) . However, Atf4 and Srebp1c mRNA expression increased with age (Fig. 2C, D) , similar to hepatic Fgf21 mRNA expression. CR did not affect hepatic Pparα expression, but it was slightly higher in fasted 9-month-old AL and CR rats. It was also slightly higher in 24-month-old AL rats and significantly higher in CR rats ( Fig. 2A) . Chrebp mRNA expression was slightly higher in CR-fed rats at 9 and 24 months of age than in younger rats. At 9 months of age, CR was associated with lower hepatic Atf4 mRNA expression, particularly in the fasted state (Fig. 2C) . In contrast, CR was associated with higher hepatic Srebp-1c mRNA expression only in the fed state in 9-and 24-month-old rats (Fig. 2D ).
In the liver, the age-associated upregulation of Fgf21 mRNA was very similar to that of Atf4. Moreover, it is likely that the CR-associated downregulation of Fgf21 expression was ACCEPTED MANUSCRIPT
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19 the result of the lower Atf4 expression at 9 months of age, particularly in the fasted state. 
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The expression of Fgf21-regulating factors in epididymal white adipose tissue
In the eWAT of AL-fed rats, Pparγ and Srebp-1c expression levels did not change throughout the experimental period (Fig. 3A, D) . However, Chrebp and Atf4 expression decreased and increased with age, respectively (Fig. 3B, C) . In the eWAT of CR-fed rats, Pparγ, Chrebp, and Srebp-1c mRNA expression was markedly elevated at 9 and 24 months of age. In addition, Pparγ and Srebp-1c mRNA expression was lower in CR-fasted rats than in CR-fed rats at 9 months of age, and at both 9 and 24 months of age, respectively.
In the eWAT, the age-associated upregulation of Fgf21 mRNA was similar to that of Atf4, 
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Fig. 3. Effects of aging and calorie restriction (CR) on FGF21-regulating gene expression in the epididymal white adipose tissue (eWAT) of Wistar rats
Total RNA was extracted from the eWAT of four groups (AL-fed, AL-fasted, CR-fed and CR-fasted) of rats at 3.5, 9, and 24 months of age. The mRNA expression of Pparγ (A), Chrebp (B), Atf4 (C) and Srebp-1c (D) was quantified using RT-qPCR (n=5-6), with Tbp being used as a reference gene and to normalize target gene expression. Values shown in all panels are means ± SEM. *P < 0.05 vs. AL, †P < 0.05 vs. fed, analyzed using the Steel-Dwass test within the same age group. §P < 0.05, § §P < 0.01 vs. 3.5 months of age, analyzed using the Steel test within the AL-fed group.
Expression of the FGF21 receptor complex and its downstream mediators in epididymal white adipose tissue
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Long-term CR was associated with significantly higher expression of Fgf21 mRNA and protein in the eWAT of fed 9-month-old rats (Fig. 1F, G, S2 ). Therefore, we next analyzed the expression of the FGF21 receptor complex and its downstream targets in eWAT in fed rats.
FGFR exists as four isoforms, FGFR1-4, with FGFR1 being the dominant isoform in adipocytes (Kurosu et al., 2007) . In AL-fed rats, Fgfr1 mRNA expression was lower at 24 months of age ( Fig. 4A ) and FGFR1 protein expression was lower at 9 and 24 months of age, than in younger rats (Fig. 4F) . However, in 24-month-old CR rats, Fgfr1 mRNA and FGFR1
protein expression were significantly and slightly restored, respectively (Fig. 4A, F) . Klb mRNA expression was much lower in older AL-fed rats (Fig. 4B ) and KLB protein expression was lower in AL-fed rats at 9 months of age (Fig. 4F) . In contrast, CR restored the age-induced reduction in Klb mRNA at both time points (Fig. 4B ) and was associated with higher KLB protein expression at 9 months of age (Fig. 4F ).
The expression of glucose transporter 1 (GLUT1) and PGC-1α is upregulated by FGF21 in adipocytes (Chau et al, 2010; Ge et al., 2011) . Although in AL-fed rats, Glut1 mRNA and protein expression did not change throughout the experimental period, at 9 months of age CR was associated with much higher Glut1 mRNA and protein expression (Fig. 4C, F, S3 ). In contrast, Glut4, which is the predominantly GLUT family member in adipocytes, showed
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23 lower mRNA expression in older animals, but CR restored this (Fig. 4D) . Pgc-1α mRNA expression also decreased with age; however, CR significantly suppressed this age-associated reduction (Fig. 4E) . 
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Total RNA was extracted from the eWAT of 3.5-month-old AL-fed, 9-month-old AL-fed and CR-fed, and 24-month-old AL-fed and CR-fed, groups of rats. The mRNA expression of Fgfr1 (A), Klb (B), Glut1 (C), Glut4
(D), and Pgc-1α (E) was quantified using RT-qPCR (n=5-6), using Tbp as a reference gene and to normalize target gene expression (A-E). Total protein was extracted from the eWAT of 3.5-month-old AL-fed, 9-month-old AL-fed and CR-fed, and 24-month-old AL-fed and CR-fed, groups of rats. FGFR1, KLB, and GLUT1 protein expression was quantified using western blotting (F, left panel), with LMNB1 being used as a reference protein and to normalize target protein expression. The quantitative data (n=5-6) are shown in the middle and right panels (F). Values shown in all panels are means ± SEM. *P < 0.05 vs. AL within the same age group, analyzed using the Mann-Whitney U-test. §P < 0.05, § §P < 0.01 vs. 3.5-month-old rats, analyzed using the Steel test within the AL-fed group.
Fgf21-overexpressing 3T3-L1s and conditioned medium treatment
To confirm the impact of CR-induced upregulation of Fgf21 expression in eWAT, we created FGF21 OE 3T3-L1 adipocytes (Fig. 5A, G) . Fgfr1 mRNA expression was not higher, but Klb mRNA expression was significantly higher in FGF21 OE 3T3-L1 adipocytes (Fig. 5B,   C ). In addition, FGFR1 protein expression was significantly higher in FGF21 OE 3T3-L1 adipocytes (Fig. 5G ), as were GLUT1 mRNA and protein expression (Fig. 5D, G) , whereas
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Glut4 mRNA expression was similar in FGF21 OE 3T3-L1 and mock adipocytes (Fig. 5E ).
Finally, FGF21 OE was associated with higher Pgc-1α expression (Fig. 5F ). shown in all panels are means ± SEM. *P < 0.05, analyzed using the Mann-Whitney U-test.
Discussion
While FGF21 is thought to exert positive endocrine/paracrine effects on glucose and lipid metabolism, increases in expression have also been reported under pathological conditions, including in the presence of mitochondrial disease (Yatsuga et al., 2015) . In the present study, we analyzed the differential effects of aging and CR on the expression of FGF21, its upstream regulatory factors, and FGF21-responsive factors in the liver and WAT.
We have shown that aging is associated with higher plasma FGF21 concentration and FGF21 expression in the liver and eWAT; that long-term CR is associated with higher expression of ACCEPTED MANUSCRIPT
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Fgf21, FGF21 receptor complex, and FGF21 downstream targets, including Glut1 and Pgc-1α, in eWAT but not in the liver of fed 9-month-old rats; and that the overexpression of FGF21 in 3T3-L1 adipocytes is also associated with higher expression of FGF21 receptor complex and its downstream targets, which is consistent with the WAT phenotype of CR rats.
Aging-associated reductions in chaperone and foldase expression promotes endoplasmic reticulum (ER) stress, resulting in the upregulation of ATF4 (Gómez-Sámano et al., 2017; Park et al., 2014) . In both eWAT and the liver, the aging-induced increase in Fgf21 expression was paralleled by that of Atf4 expression. Similarly, aging was associated with higher Fgf21 expression in the liver and eWAT, and higher plasma FGF21 in AL-fed rats.
Thus, taken together, these data suggest that aging may promote ER stress in the liver and eWAT, which induces Fgf21 expression via Atf4 activation, and results in higher plasma FGF21 concentrations. The increase in plasma FGF21 concentration that occurs under pathological conditions may reflect "FGF21 resistance", which has been shown in obesity (Fisher et al., 2010; Zhang et al., 2008) . Furthermore, obesity is associated with lower chaperone-mediated protein folding capacity and higher ER stress (Pagliassotti et al., 2016) .
Therefore, we consider that the age-associated increase in FGF21 might reflect FGF21 resistance, as well as obesity.
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The plasma FGF21 concentration, and the expression of FGF21 protein and Fgf21 transcript, increased nearly in parallel in both the liver and eWAT with age. It has been reported that hepatic Fgf21 mRNA expression and plasma FGF21 concentration are often correlated, and it is likely that the basal level of and fasting-induced increase in plasma FGF21 are largely determined by its release from the liver (Dutchak et al., 2012; Markan et al., 2014) . However, the age-associated increase in plasma FGF21 concentration might also be influenced by secretion from WAT. The CR-and fasting-associated alterations in plasma FGF21 concentration, FGF21 protein, and Fgf21 transcript did not correlate, but the reasons for this are not clear. At 9 and 24 months of age, the plasma FGF21 concentration was much lower in the fasted than in the fed state in CR rats, but not in AL rats. Sun et al. (2012) reported that CR suppresses plasma FGF21 concentration, but conversely, Zhang et al. (2012) showed that CR does not affect circulating FGF21 levels. This discrepancy could be due to differences in experimental conditions, including animal species, strain, feeding status at euthanasia, and duration of CR. However, it appears that feeding status significantly affects plasma FGF21 concentration, especially during CR.
In the liver of 9-month-old CR-fasted rats Fgf21 and Atf4 mRNAs expression was lower,
suggesting that ATF4 might regulate Fgf21 transcription, particularly in the fasted state in CR ACCEPTED MANUSCRIPT
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rats. In addition, Fgf21 mRNA expression was lower in 24-month-old CR-fed rats. This downregulation may be associated with the upregulation of Srebp-1c, which inhibits Fgf21 expression in hepatocytes (Zhang et al., 2011) . CR upregulates PPARγ and SREBP1 at the protein level in eWAT (Stelmanska et al., 2004 , Qiao et al., 2011 , and indeed we show here that Fgf21 and its upstream positive regulators Pparγ, Chrebp, and Srebp1c were all upregulated in the eWAT of 9-month-old CR-fed rats. Therefore, we hypothesize that CR might upregulate Pparγ, Chrebp, and Srebp1c, resulting in higher Fgf21 expression in WAT.
However, in the present study the expression of FGF21-regulating factors was only assessed at the mRNA level. Therefore, further investigation of the transcriptional regulation of Fgf21 is required.
In KLB KO mice, the effect of FGF21 on WAT metabolism is abrogated (Adams et al., 2012) . Moreover, the acute insulin-sensitizing effects of FGF21 are blunted in aP2-Cre KLB KO mice (Ding et al., 2012) , suggesting that KLB expression is essential for the effects of FGF21 in WAT. The expression level of the FGF21 receptor complex, particularly Klb mRNA expression, decreased with age, but was restored by CR in eWAT. Klb expression was also lower in the WAT of diet-induced obese mice, implying FGF21 resistance (Fisher et al., 2010) .
In addition, Pparγ expression was higher in CR-fed mice at both 9 and 24 months of age.
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Glut4 mRNA expression at 9 and 24 months of age. However, FGF21 OE 3T3-L1 adipocytes showed higher Glut1 expression, but no difference in Glut4 expression, which is consistent with the results of Li et al. (2012) . It has been reported that KLB, which is necessary for FGF21 signal transduction, is also upregulated by FGF21 (Adams et al., 2012; Li et al., 2012) .
There was higher expression of KLB, GLUT1, and FGF21 in 9-month-old rats, suggesting that GLUT1 expression may be regulated by FGF21-FGFR/KLB signaling. Furthermore, treatment with conditioned medium (CM) derived from FGF21 OE 3T3-L1 adipocytes increased Glut1 mRNA expression (Fig. S4A ). These data suggest that CR might promote both insulin-stimulated glucose uptake through GLUT4 and basal glucose uptake through FGF21-induced GLUT1 hyperexpression in 9 months old rats, but only through GLUT4 at 24
A C C E P T E D M A N U S C R I P T 31 months of age. It has been reported that fat-specific insulin receptor KO mice live longer that wild-type mice (Blüher et al., 2003) , and it is widely accepted that growth hormone/IGF-1/insulin signaling is a negative regulator of lifespan (Gesing et al., 2014) .
Moreover, in CR animals, fasting plasma insulin concentrations are lower than that in AL animals (Gesing et al., 2014) . Thus, when taken together, these findings suggest that the insulin-independent glucose uptake via GLUT1 might contribute to the improvement in whole body-metabolism, in cooperation with improved insulin-stimulated glucose uptake via
GLUT4.
The expression of PGC-1α, which plays a critical role in mitochondrial biogenesis (Anderson et al., 2008) , was higher in the WAT of CR-fed rats at 9 and 24 months of age, and also in FGF21 OE 3T3-L1 adipocytes. However, treatment with CM derived from FGF21 OE 3T3-L1 adipocytes did not increase Pgc-1α mRNA expression (Fig. S4B) . The regulatory mechanisms of PGC-1α have been studied in some detail. We have demonstrated that CR transcriptionally upregulates Pgc-1α expression via SREBP-1c (Fujii et al., 2017) , whereas
Pgc-1α is transcriptionally downregulated by forkhead box protein A3 (FOXA3) (Ma et al., 2014) , and post-transcriptionally regulated by pathways including the FGF21-AMP-activated protein kinase (AMPK)-sirtuin 1 (SIRT1)-PGC-1α pathway (Chau et al., 2010) . Therefore,
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A C C E P T E D M A N U S C R I P T 32 our present finding of CR-associated upregulation of Pgc-1α in 9-month-old rats might be the result of regulation by SREBP-1c and FGF21. In contrast, at 24 months of age, its CR-induced upregulation might be mediated by SREBP-1c and related mechanisms, but not by FGF21. CR increases glucose uptake (Fabbiano et al., 2016) and activates mitochondrial biogenesis in WAT (Fujii et al., 2017; Okita et al., 2012) . Hence, it is likely that CR-induced upregulation of FGF21 signaling stimulates both glucose uptake via GLUT1 and mitochondrial biogenesis via PGC-1α, in WAT at 9 months of age, but through neither mechanism at 24 months of age.
In conclusion, our data suggest that aging induces Fgf21 expression in the eWAT and liver, and that this might be regulated by ATF4, which is associated with ER stress. Moreover, the age-associated increase in Fgf21 expression might be the result of FGF21 resistance. We have also shown evidence that CR activates the FGF21-FGFR1/KLB-GLUT1/PGC-1α pathway in eWAT. We have previously suggested that WAT remodeling is important for the anti-aging and pro-longevity effects of CR (Fujii et al., 2017) . We show here that higher expression of FGF21 and its downstream targets may play a pivotal role in CR-induced WAT remodeling, which involves enhanced glucose uptake and mitochondrial biogenesis. However, these effects were attenuated at a late stage of aging. To our knowledge, ongoing CR research
A C C E P T E D M A N U S C R I P T 33 focuses on two themes: the elucidation of the molecular mechanisms of CR and the development of CR-mimetic drugs. FGF21 may be an important target to be considered in the development of CR mimetic drugs, but may also represent a promising drug target in type 2 diabetes and obesity, and indeed trials are currently in progress (Gaich et al., 2013; Kim et al., 2017) . Moreover, agonistic KLB antibodies mimic FGF21 function (Min et al., 2018) .
Therefore, further investigation of the regulation of FGF21 signaling should assist with the development of CR mimetic drugs and may also identify valuable therapeutic strategies for metabolic syndrome.
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• Aging elevated plasma fibroblast growth factor 21 (FGF21) concentrations.
• Aging also increased FGF21 expression in liver and white adipose tissue (WAT).
• Long-term CR further increased FGF21 expression in WAT but not liver.
• Aging inhibited FGF21 signaling and CR canceled this inactivation in WAT.
• FGF21 signaling may partially contribute to CR-associated remodeling of WAT.
